Enrich Biosystems Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 14

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $4.44M

  • Investors
  • 15

Enrich Biosystems General Information

Description

Developer of a novel single-cell isolation technology designed to enhance biomedical research at a true single-cell level. The company's technology uses non-fluidics, dissolvable microwells and visual enrichment strategies to eliminate insurmountable pain points from existing technologies, enabling healthcare professionals to get a streamlined workflow of cell culturing, kinetics profiling and guided capturing based on cell functions.

Contact Information

Formerly Known As
Enrich Therapeutics
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 21 Business Park Drive
  • Suite 4
  • Branford, CT 06405
  • United States
+1 (203)
Primary Industry
Biotechnology
Corporate Office
  • 21 Business Park Drive
  • Suite 4
  • Branford, CT 06405
  • United States
+1 (203)

Enrich Biosystems Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Enrich Biosystems Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Seed Round 26-Nov-2025 $4.44M Completed Generating Revenue
10. Accelerator/Incubator 30-Sep-2023 Completed Generating Revenue
9. Seed Round 16-May-2022 Completed Generating Revenue
8. Grant 01-Jan-2022 Completed Generating Revenue
7. Accelerator/Incubator 30-May-2021 Completed Generating Revenue
6. Grant 21-Aug-2020 Completed Generating Revenue
5. Grant 14-Aug-2020 Completed Generating Revenue
4. Seed Round 11-May-2020 Completed Generating Revenue
3. Grant 01-Sep-2019 $225K Completed Generating Revenue
2. Accelerator/Incubator 01-Jan-2019 Completed Product In Beta Test
To view Enrich Biosystems’s complete valuation and funding history, request access »

Enrich Biosystems Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed
To view Enrich Biosystems’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Enrich Biosystems Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a novel single-cell isolation technology designed to enhance biomedical research at a true single-cell leve
Biotechnology
Branford, CT
14 As of 2025

Cambridge, United Kingdom
 

Shirley, NY
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Enrich Biosystems Competitors (47)

One of Enrich Biosystems’s 47 competitors is bit.bio, a Venture Capital-Backed company based in Cambridge, United Kingdom.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
bit.bio Venture Capital-Backed Cambridge, United Kingdom
CD Genomics Corporation Shirley, NY
Novus Biologicals Formerly PE-Backed Centennial, CO
LevitasBio Venture Capital-Backed Hayward, CA
MatTek Corporate Backed or Acquired Ashland, MA
You’re viewing 5 of 47 competitors. Get the full list »

Enrich Biosystems Patents

Enrich Biosystems Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2023239895-A1 Methods of reducing noise and ambiguity in single cell analysis Inactive 09-Jun-2022
EP-4319918-A1 Destructible microwell arrays for particle separation and analysis Pending 02-May-2021
EP-4319918-A4 Destructible microwell arrays for particle separation and analysis Pending 02-May-2021
US-20240191183-A1 Destructible microwell arrays for particle separation and analysis Pending 02-May-2021
WO-2022235507-A1 Destructible microwell arrays for particle separation and analysis Inactive 02-May-2021 C12N5/0068
To view Enrich Biosystems’s complete patent history, request access »

Enrich Biosystems Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Enrich Biosystems Investors (15)

Investor Name Investor Type Holding Investor Since Participating Rounds
Aimers Venture Partners Venture Capital Minority
Massachusetts Biomedical Initiatives Accelerator/Incubator
Decent Capital Family Office Minority
Elm Street Ventures VC-Backed Company Minority
Taihill Venture Venture Capital Minority
You’re viewing 5 of 15 investors. Get the full list »

Enrich Biosystems FAQs

  • When was Enrich Biosystems founded?

    Enrich Biosystems was founded in 2018.

  • Where is Enrich Biosystems headquartered?

    Enrich Biosystems is headquartered in Branford, CT.

  • What is the size of Enrich Biosystems?

    Enrich Biosystems has 14 total employees.

  • What industry is Enrich Biosystems in?

    Enrich Biosystems’s primary industry is Biotechnology.

  • Is Enrich Biosystems a private or public company?

    Enrich Biosystems is a Private company.

  • What is Enrich Biosystems’s current revenue?

    The current revenue for Enrich Biosystems is .

  • How much funding has Enrich Biosystems raised over time?

    Enrich Biosystems has raised $8.64M.

  • Who are Enrich Biosystems’s investors?

    Aimers Venture Partners, Massachusetts Biomedical Initiatives, Decent Capital, Elm Street Ventures, and Taihill Venture are 5 of 15 investors who have invested in Enrich Biosystems.

  • Who are Enrich Biosystems’s competitors?

    bit.bio, CD Genomics, Novus Biologicals, LevitasBio, and MatTek are some of the 47 competitors of Enrich Biosystems.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process